HealthEquity (HQY) Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HQY shares.
View HQY analyst ratings or view top-rated stocks.

8 brokers have issued 12 month price targets for HealthEquity's stock. Their HQY share price forecasts range from $72.00 to $94.00. On average, they predict the company's stock price to reach $84.00 in the next year. This suggests a possible upside of 14.3% from the stock's current price.
View analysts price targets for HQY or view top-rated stocks among Wall Street analysts.

HealthEquity's stock was trading at $61.64 on January 1st, 2023. Since then, HQY stock has increased by 19.2% and is now trading at $73.50.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our HQY earnings forecast.

HealthEquity, Inc. (NASDAQ:HQY) posted its earnings results on Tuesday, September, 5th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.28 by $0.06. The company earned $243.55 million during the quarter, compared to analyst estimates of $238.89 million. HealthEquity had a trailing twelve-month return on equity of 5.08% and a net margin of 1.37%.

ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Nuveen Small Cap Select ETF (NSCS), Putnam Sustainable Future ETF (PFUT) and iShares U.S. Healthcare Providers ETF (IHF).

HealthEquity updated its FY24 earnings guidance on Tuesday, September, 5th. The company provided earnings per share guidance of $1.97-$2.06 for the period, compared to the consensus estimate of $1.93. The company issued revenue guidance of $980-$990 million, compared to the consensus revenue estimate of $981.09 million.

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQY stock can currently be purchased for approximately $73.50.

HealthEquity (NASDAQ:HQY) has a market capitalization of $6.29 billion and generates $861.75 million in revenue each year. The company earns $-26,140,000.00 in net income (profit) each year or $0.15 on an earnings per share basis.

The company employs 3,208 workers across the globe.

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.